Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia

Ayami Yoshimi, Irith Baumann, Monika Führer, Eva Bergsträsser, Ulrich Göbel, Karl Walter Sykora, Thomas Klingebiel, Ute Gross-Wieltsch, Marry M. Van Den Heuvel-Eibrink, Alexandra Fischer, Peter Nöllke, Charlotte Niemeyer

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Abstract

It is currently unknown whether immunosuppressive therapy or hematopoietic stem cell transplantation is the most appropriate treatment strategy for children with refractory cytopenia and normal karyotype or trisomy 8. We report on 31 children with hypoplastic refractory cytopenia treated with immunosuppressive therapy consisting of antithymocyte globulin and cyclosporine. At 6 months, 22 of 29 evaluable patients had a complete or partial response; a total of ten patients achieved a complete response at varying time points. Six patients subsequently received a transplant because of non-response, progression to advanced myelodysplastic syndrome or evolution of monosomy 7. Overall and failure-free survival rates at 3 years were 88% and 57%, respectively.

Original languageEnglish
Pages (from-to)397-400
Number of pages4
JournalHaematologica
Volume92
Issue number3
DOIs
Publication statusPublished - Mar 2007
Externally publishedYes

Keywords

  • Anti-thymocyte globulin
  • Children
  • Immunosuppressive therapy
  • Myelodysplastic syndrome
  • Refractory cytopenia

Fingerprint

Dive into the research topics of 'Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia'. Together they form a unique fingerprint.

Cite this